• Syros Pharmaceuticals (NASDAQ:SYRS) Earns "Neutral" Rating from HC Wainwright

    Source: Buzz FX / 13 Nov 2024 07:56:17   America/Chicago


    Syros Pharmaceuticals (NASDAQ:SYRS) Earns "Neutral" Rating from HC Wainwright Written by MarketBeat November 13, 2024 Share Link copied to clipboard. Syros Pharmaceuticals ( NASDAQ:SYRS - Get Free Report ) 's stock had its "neutral" rating
    Read more...
Share on,